The Board of Directors of Mereo BioPharma recognises the importance of sound corporate governance and strives, where practicable for a company of its size and nature to comply with the standards of good practice prescribed by the UK Corporate Governance Code (2012) in its four specified areas:
- Board leadership and effectiveness;
- Directors’ remuneration;
- Accountability with respect to financial practices; and
- Relations with shareholders
The Mereo Group has adopted an Anti-Bribery and Anti-Corruption Policy in order to ensure compliance with the UK Bribery Act (2010). The Board has appointed a “compliance officer” to oversee compliance with the policy.
The Board of Directors has established an Audit and Risk Committee, a Remuneration and a Nominations Committee, and a Research and Development Committee, with formally delegated duties and responsibilities.
Never miss an update from Mereo. Sign up for and select the type of alerts you would like to receive by email.Register for Email Alerts
Share Price Information
Mereo is a specialty biopharma company developing innovative medicines for patients. Find out about our share price and latest trades.View Share Price